Miositis viral aguda del adulto

Gil, Iván J. Núñez; Álvarez-Rodríguez, Esther; García, M. J. Amérigo; Cardeñosa, A. Braña; Vidal, Luis Diaz; Cobos, Rocío García

doi:10.4321/s0212-71992006000200015

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Intense physical exercise, trauma, generalized tonic-clonic seizures, acute psychosis, systemic connective tissue diseases, renal or cardiac failure, viral diseases that cause myopathies such as influenza, coxsackie, adenovirus, prostate cancer, celiac disease, obstructive sleep apnea, moderate to severe hypothyroidism, drugs such as statins, fibrates, antiretrovirals, beta-blockers, clozapine, angiotensin II receptor antagonists, hydroxychloroquine, isotretinoin, and colchicine; neuromuscular diseases such as Guillain Barré, amyotrophic lateral sclerosis, myopathy due to the use of corticosteroids, hyperthyroidism, collagen diseases, alcoholism, procedures such as intramuscular injections and electromyography have been described as possible etiologies. [6][7][8][9][10][11][12] Besides that, the most frequent causes of CPK elevation are genetic diseases such as muscular dystrophies, congenital myopathies, channelopathies, mitochondrial myopathies, and myotonic dystrophies, although exercise can also temporarily increase CPK levels due to rhabdomyolysis. 2,13 Muscular dystrophies are classified according to their genetic transmission mechanism, either autosomal dominant or recessive, and those linked to the X chromosome.…”

Section: Introductionmentioning

confidence: 99%

Diagnostic strategies for muscular dystrophies: a cross-sectional study

Hanna Rodriguez,

Estrada-Alvarez,

Guillermo Murillo

et al. 2024

F1000Res

View full text Add to dashboard Cite

Background Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Many patients remain underdiagnosed or misdiagnosed consequently affecting their prognosis and quality of life. Therefore, we aimed to establish clinical and molecular characteristics of patients with increased CPK levels and muscular dystrophies in our region to facilitate diagnosis and follow-up on patients with suspected muscular dystrophies. Methods A cross-sectional study was made using a retrospective search of patients attended in Comfamiliar Risaralda between 2010 and 2021. The study included patients from both genders and all ages who presented with a diagnosis of polymyositis, myoclonus, myopathy, and muscular dystrophy between 2010 and 2022 in Comfamiliar Risaralda. Patients with CPK levels lower than 500 U/L were excluded. Results A database analysis was carried out from 2010 to 2022 of 5219 patients treated in a fourth-level care institution in the Eje Cafetero region, finding 221 patients filtered by a diagnosis of myopathy, myoclonus, polymyositis, and dystrophy. We found a combined prevalence of all muscular dystrophies of 4.2 per 100.000 among patients treated in our hospital base, Duchenne muscular dystrophy of 0.6 per 100.000, limb-girdle muscular dystrophy of 0.6 per 100.000, facioscapulohumeral dystrophy of 0.5 per 100.000, Bethem dystrophy, type 2 Emery Dreifuss muscular dystrophy, merosin-deficient muscular dystrophy and myosin storage disease of 0.1 per 100.000. A diagnostic sequence was elaborated from clinical and paraclinical features found in our patients. A diagnostic sequence was elaborated from clinical and paraclinical features found in our patients. Conclusions Although muscular dystrophies consist of a heterogeneous group of neuromuscular diseases, there are still clinical and paraclinical features that can help physicians to detect any particular case and perform a good approach and follow-up. Our diagnostic sequence will facilitate physicians to determine any particular muscular dystrophy.

show abstract

Section: Introductionmentioning

confidence: 99%

Diagnostic strategies for muscular dystrophies: a cross-sectional study

Hanna Rodriguez,

Estrada-Alvarez,

Guillermo Murillo

et al. 2024

F1000Res

View full text Add to dashboard Cite

show abstract

Sporadic acute benign calf myositis: Systematic literature review

Capoferri

Milani

Ramelli

et al. 2018

Neuromuscular Disorders

View full text Add to dashboard Cite

Diagnostic strategies for muscular dystrophies: a cross-sectional study

Rodriguez¹,

Estrada-Álvarez²,

Murillo

et al. 2023

F1000Res

View full text Add to dashboard Cite

Background: Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Many patients remain underdiagnosed o misdiagnosed consequently affecting their prognosis and quality of life. Therefore, we aimed to establish clinical and molecular characteristics of patients with increased CPK levels and muscular dystrophies in our region to facilitate diagnosis and follow-up on patients with suspected muscular dystrophies. Methods: A cross-sectional study was made using a retrospective search of patients attended in Comfamiliar Risaralda between 2010 and 2021. The study included patients from both genders and all ages who presented with a diagnosis of polymyositis, myoclonus, myopathy, and muscular dystrophy between 2010 and 2022 in Comfamiliar Risaralda. Patients with CPK levels lower than 500 U/L were excluded. Results: A database analysis was carried out from 2010 to 2022 of 5219 patients treated in a fourth-level care institution in the Eje Cafetero region, finding 221 patients filtered by a diagnosis of myopathy, myoclonus, polymyositis, and dystrophy. We found a combined prevalence of all muscular dystrophies of 4.2 per 100.000 habitants, Duchenne muscular dystrophy of 0.6 per 100.000 habitants, limb-girdle muscular dystrophy of 0.6 per 100.000 habitants, facioscapulohumeral dystrophy of 0.5 per 100.000 habitants, Bethem dystrophy, type 2 Emery Dreifuss muscular dystrophy and merosin-deficient muscular dystrophy of 0.1 per 100.000 habitants. A diagnostic sequence was elaborated from clinical and paraclinical features found in our patients. Conclusions: Although muscular dystrophies consist of a heterogeneous group of neuromuscular diseases, there are still clinical and paraclinical features that can help physicians to detect any particular case and perform a good approach and follow-up. Our diagnostic sequence will facilitate physicians to determine any particular muscular dystrophy.

show abstract

Miositis viral aguda del adulto

Cited by 3 publications

References 0 publications

Diagnostic strategies for muscular dystrophies: a cross-sectional study

Diagnostic strategies for muscular dystrophies: a cross-sectional study

Sporadic acute benign calf myositis: Systematic literature review

Diagnostic strategies for muscular dystrophies: a cross-sectional study

Contact Info

Product

Resources

About